DZ315A1 - Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant. - Google Patents

Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant.

Info

Publication number
DZ315A1
DZ315A1 DZ816254A DZ816254A DZ315A1 DZ 315 A1 DZ315 A1 DZ 315A1 DZ 816254 A DZ816254 A DZ 816254A DZ 816254 A DZ816254 A DZ 816254A DZ 315 A1 DZ315 A1 DZ 315A1
Authority
DZ
Algeria
Prior art keywords
encaspsule
pharmaceutical composition
composition containing
acid addition
addition salt
Prior art date
Application number
DZ816254A
Other languages
English (en)
Inventor
Morgan Lee Beatty
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DZ315A1 publication Critical patent/DZ315A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
DZ816254A 1980-08-22 1981-07-08 Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant. DZ315A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/180,537 US4321253A (en) 1980-08-22 1980-08-22 Suspension of microencapsulated bacampicillin acid addition salt for oral, especially pediatric, administration

Publications (1)

Publication Number Publication Date
DZ315A1 true DZ315A1 (fr) 2004-09-13

Family

ID=22660812

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ816254A DZ315A1 (fr) 1980-08-22 1981-07-08 Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant.

Country Status (41)

Country Link
US (1) US4321253A (fr)
JP (1) JPS5775986A (fr)
KR (1) KR860000513B1 (fr)
AR (1) AR227201A1 (fr)
AT (1) AT370994B (fr)
AU (1) AU529965B2 (fr)
BE (1) BE890028A (fr)
BG (1) BG42000A3 (fr)
CA (1) CA1137414A (fr)
CH (1) CH650674A5 (fr)
CS (1) CS225845B2 (fr)
DD (1) DD201644A5 (fr)
DE (1) DE3132614C2 (fr)
DK (1) DK158971C (fr)
DZ (1) DZ315A1 (fr)
ES (1) ES504905A0 (fr)
FI (1) FI72647C (fr)
FR (1) FR2488798A1 (fr)
GB (1) GB2082539B (fr)
GR (1) GR74983B (fr)
HK (1) HK43786A (fr)
HU (1) HU188679B (fr)
IE (1) IE51506B1 (fr)
IL (1) IL63617A (fr)
IN (1) IN156538B (fr)
IT (1) IT1138161B (fr)
KE (1) KE3626A (fr)
LU (1) LU83572A1 (fr)
MX (1) MX5731A (fr)
MY (1) MY8600597A (fr)
NL (1) NL191978C (fr)
NO (1) NO154821C (fr)
NZ (1) NZ198106A (fr)
PH (1) PH17125A (fr)
PL (1) PL232141A1 (fr)
PT (1) PT73555B (fr)
RO (1) RO82679B (fr)
SE (1) SE448819B (fr)
SU (1) SU1364226A3 (fr)
YU (1) YU43985B (fr)
ZA (1) ZA815793B (fr)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2950977A1 (de) * 1978-12-22 1980-07-10 Donald E Panoz Neue galenische zubereitungsform fuer die orale verabreichung von medikamenten mit programmierter besetzung, sowie verfahren zu ihrer herstellung
SE8103843L (sv) * 1981-06-18 1982-12-19 Astra Laekemedel Ab Farmaceutisk mixtur
US4994260A (en) * 1982-05-28 1991-02-19 Astra Lakemedel Aktiebolag Pharmaceutical mixture
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
EP0111560A4 (fr) * 1982-06-14 1987-02-03 Key Pharma Aspirine a liberation entretenue.
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
US4634587A (en) * 1982-07-09 1987-01-06 Key Pharmaceuticals, Inc. Sustained release quinidine dosage form
EP0113373B1 (fr) * 1982-07-09 1991-08-28 Key Pharmaceuticals, Inc. Forme de dosage de quinidine a liberation entretenue
AU569277B2 (en) * 1983-03-03 1988-01-28 Dow Chemical Company, The Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
SE8405611D0 (sv) * 1984-11-09 1984-11-09 Astra Laekemedel Ab Process for stabilization of bacampicillin hydrochloride
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
US4853229A (en) * 1987-10-26 1989-08-01 Alza Corporation Method for adminstering tiny pills
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
DE69309052T2 (de) * 1992-04-30 1997-06-19 Schering Corp Oral anzuwendende suspension bestehend aus stabilisiertem rockenpulver eines hydratisierten cephalosporins
US6270795B1 (en) 1995-11-09 2001-08-07 Microbiological Research Authority Method of making microencapsulated DNA for vaccination and gene therapy
US6270804B1 (en) * 1998-04-03 2001-08-07 Biovail Technologies Ltd. Sachet formulations
IN191482B (fr) * 1999-03-19 2003-12-06 Ranbaxy Lab Ltd
JP4711478B2 (ja) * 1999-08-13 2011-06-29 旭化成ケミカルズ株式会社 味がマスクされた薬物
US20050037086A1 (en) * 1999-11-19 2005-02-17 Zycos Inc., A Delaware Corporation Continuous-flow method for preparing microparticles
AP2002002552A0 (en) 1999-12-23 2002-06-30 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations.
EP1118333A1 (fr) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions avec une biodisponibilité orale augmentée
ATE361061T1 (de) 2000-04-20 2007-05-15 Novartis Ag Beschichtungszusammensetzung zur geschmacksmaskierung
US6551617B1 (en) 2000-04-20 2003-04-22 Bristol-Myers Squibb Company Taste masking coating composition
AU2001268159B2 (en) * 2000-06-02 2005-09-15 Eisai Inc. Delivery systems for bioactive agents
FR2822834B1 (fr) * 2001-04-02 2005-02-25 Flamel Tech Sa Suspension colloidale de nanoparticules a base de copolymeres amphiphile pour la vectorisation de principes actifs et leur mode de preparation
WO2002096392A1 (fr) * 2001-05-31 2002-12-05 Cima Labs Inc. Masquage du gout de medicaments hautement hydrosolubles
KR20030015655A (ko) * 2001-08-17 2003-02-25 한미약품공업 주식회사 항암제의 경구흡수율을 증가시키는 인단계 화합물의결정성 산부가염, 이의 제조방법 및 이를 함유하는 약학적조성물
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ATE419840T1 (de) 2002-04-09 2009-01-15 Flamel Tech Sa Orale wässrige suspension, mikrokapseln enthaltend, zur kontrollierten freisetzung von wirkstoffen
IL164221A0 (en) * 2002-04-09 2005-12-18 Flamel Tech Sa Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillim
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
FR2842736B1 (fr) 2002-07-26 2005-07-22 Flamel Tech Sa Formulation pharmaceutique orale sous forme d'une pluralite de microcapsules permettant la liberation prolongee de principe(s) actif(s) peu soluble(s)
FR2843117B1 (fr) * 2002-07-30 2004-10-15 Flamel Tech Sa Polyaminoacides fonctionnalises par au moins un groupement hydrophobe et leurs applications notamment therapeutiques
US7632521B2 (en) * 2003-07-15 2009-12-15 Eurand, Inc. Controlled release potassium chloride tablets
FR2860516B1 (fr) * 2003-10-03 2006-01-13 Flamel Tech Sa Homopolyaminoacides telecheliques fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
FR2862536B1 (fr) * 2003-11-21 2007-11-23 Flamel Tech Sa Formulations pharmaceutiques pour la liberation prolongee de principe(s) actif(s), ainsi que leurs applications notamment therapeutiques
US7244765B2 (en) * 2004-06-25 2007-07-17 Cytokine Pharmasciences, Inc Guanylhydrazone salts, compositions, processes of making and methods of using
FR2885526B1 (fr) * 2005-05-13 2007-07-27 Flamel Technologies Sa Medicament oral a base d'inhibiteur de pompe a protons
US20180177820A1 (en) * 2015-10-13 2018-06-28 Techno Guard Co. Ltd. Protective composition for gastrointestinal mucosa

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549746A (en) * 1967-11-02 1970-12-22 Bristol Myers Co Antibiotic composition
US3873521A (en) * 1970-09-17 1975-03-25 Astra Laekemedel Ab Esters of {60 -amino penicillins
ZA718014B (en) 1970-12-23 1972-08-30 Beecham Group Ltd Pharmaceutical formulations
US4016254A (en) * 1972-05-19 1977-04-05 Beecham Group Limited Pharmaceutical formulations
GB1455296A (en) * 1973-05-24 1976-11-10 Beecham Group Ltd Veterinary treatment
GB1479655A (en) 1974-03-08 1977-07-13 Beecham Group Ltd Antibiotic preparations
US4127647A (en) * 1975-04-08 1978-11-28 Meiji Seika Kaisha, Ltd. Process for preparation of stable amorphous macrolide antibiotic solids
JPS5840529B2 (ja) * 1975-09-29 1983-09-06 明治製菓株式会社 ケイコウヨウセイザイノセイホウ
GB1561301A (en) * 1976-01-02 1980-02-20 Beecham Group Ltd Orally administrable pharmaceutical composition
ZA793935B (en) * 1978-08-04 1980-07-30 Beecham Group Ltd Powders
JPS57105316A (en) * 1980-12-23 1982-06-30 Hitachi Cable Ltd Method of fitting heat-shrinkable tube

Also Published As

Publication number Publication date
DK372181A (da) 1982-02-23
RO82679A (fr) 1984-05-23
US4321253A (en) 1982-03-23
YU43985B (en) 1990-02-28
SU1364226A3 (ru) 1987-12-30
KR860000513B1 (ko) 1986-05-02
GR74983B (fr) 1984-07-12
PH17125A (en) 1984-06-01
IE811911L (en) 1982-02-22
IT8123587A0 (it) 1981-08-20
AT370994B (de) 1983-05-25
NO812827L (no) 1982-02-23
DK158971C (da) 1991-01-07
NZ198106A (en) 1983-12-16
NL8103902A (nl) 1982-03-16
AU529965B2 (en) 1983-06-30
KE3626A (en) 1986-05-16
MX5731A (es) 1993-11-01
PT73555A (en) 1981-09-01
LU83572A1 (fr) 1982-04-14
IN156538B (fr) 1985-08-31
DK158971B (da) 1990-08-13
GB2082539B (en) 1984-01-18
NO154821B (no) 1986-09-22
RO82679B (ro) 1984-07-30
HK43786A (en) 1986-06-20
JPH0248525B2 (fr) 1990-10-25
FI72647C (fi) 1987-07-10
IT1138161B (it) 1986-09-17
CA1137414A (fr) 1982-12-14
DE3132614C2 (de) 1985-08-22
CH650674A5 (fr) 1985-08-15
NO154821C (no) 1987-01-07
NL191978B (nl) 1996-08-01
FR2488798B1 (fr) 1985-01-11
FI812574L (fi) 1982-02-23
FI72647B (fi) 1987-03-31
HU188679B (en) 1986-05-28
BE890028A (fr) 1982-02-22
ES8303091A1 (es) 1983-02-01
ATA362781A (de) 1982-10-15
SE448819B (sv) 1987-03-23
ZA815793B (en) 1982-08-25
CS225845B2 (en) 1984-02-13
BG42000A3 (en) 1987-09-15
DD201644A5 (de) 1983-08-03
SE8104974L (sv) 1982-02-23
DE3132614A1 (de) 1982-05-19
MY8600597A (en) 1986-12-31
PT73555B (en) 1983-07-14
JPS5775986A (en) 1982-05-12
AR227201A1 (es) 1982-09-30
IL63617A (en) 1984-11-30
FR2488798A1 (fr) 1982-02-26
IE51506B1 (en) 1987-01-07
GB2082539A (en) 1982-03-10
IL63617A0 (en) 1981-11-30
NL191978C (nl) 1996-12-03
AU7441681A (en) 1982-04-01
PL232141A1 (fr) 1982-03-15
ES504905A0 (es) 1983-02-01
YU201781A (en) 1984-04-30
KR830005850A (ko) 1983-09-14

Similar Documents

Publication Publication Date Title
DZ315A1 (fr) Poudre à base de sel d'addition d'acide de bacampicilline micro-encaspsule et composition pharmaceutique la contenant.
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
FR2602974B1 (fr) Composition pharmaceutique contenant de la nicotine ou ses derives
BE860794A (fr) Poudre ou granules contenant de l'acide sorbique
FR2505835B1 (fr) Nouvelles 1,2-diaminocyclobutene-3,4-diones, leur procede de preparation et composition pharmaceutique les contenant
MC1915A1 (fr) Procédés pour la préparation de 2',3'-didésoxynucléosides et de formulations pharmaceutiques en contenant
FR2411839B1 (fr) Derives de l'acide cephalosporanique, procedes pour leur preparation et composition pharmaceutique les contenant
BE880065A (fr) Nouvelles spiro-polycyclo-imidazolidinediones et composition pharmaceutique les contenant
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
BE879472A (fr) Composition pharmaceutique contenant des 3,4-dihydro-3-oxo-2-quinoxalines
FR2608921B1 (fr) Composition pharmaceutique contenant de la ranitidine
FR2446819B1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2450814B1 (fr) 24,24-difluoro-25-hydroxycholecalciferol et composition pharmaceutique renfermant ce produit
IT8520234A0 (it) Composizione farmaceutiche adattivita' dopominergica.
FR2609392B1 (fr) Compositions pharmaceutiques contenant des pyranoquinoleines
FR2509611B1 (fr) Nouvel agent anti-acide et composition pharmaceutique le contenant
BE864027A (fr) Procede de preparation de l'alpha-2,5,9-trimethylbenzo-(b)-thieno-(2,3,f)-morphane, produit obtenu et composition pharmaceutique le contenant
PT77767B (fr) Procede de preparation de 3',5'-diarabinosides et de compositi-ons pharmaceutiques les contenant
FR2512342B1 (fr) Composition pharmaceutique contenant un medicament anti-inflammatoire et de la ranitidine ou un sel de ce compose
DZ1748A1 (fr) Sel de lysine du 6-chloro-5-fluoro-3-(2-thénoyl)-2-oxindole-1-carboxamide et composition pharmaceutique le contenant.
PT87828A (pt) Procede de preparation d'herbicides de type sulfonyluree et de compositions herbicides les contenant
IT8222593A0 (it) Procedimento di preparazione dell'erbicida phenmedipham.
FR2601950B1 (fr) N,n-dimethyl-n'-benzoyl-n' ((2,3-dihydro) benzofuran-2-yl-methyl) 1,3-propanediamine, preparation et compositions pharmaceutiques les contenant